← All Sponsors
SPONSOR

SyneuRx International (Taiwan) Corp

Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Conditions studied: Refractory Schizophrenia
NCT03094429 Phase 2, Phase 3
Recruiting

An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults

Refractory Schizophrenia
United States View Trial →